KCI’s Wound Care Products Approved for Military Aircraft Use
Kinetic Concepts Inc (KCI, San Antonio, Tex) received the Joint Airworthiness Certification from the US Army and the US Air Force for its V.A.C.® Freedom wound care device.
After an extensive evaluation process to test the device’s safety for use on military medical evacuation aircraft, the military can now use V.A.C. Freedom on the Air Force’s C-17, C-5, KC-135, C-130, KC-10, and Army’s military helicopters.
Through this certification, Army and Air Force medical personnel are now authorized to use the KCI’s medical equipment in the air while treating injured soldiers. Those serving in Iraq, Afghanistan, or other locations will not have to suspend their treatment en route back to the United States.
This device will support countless soldiers wounded in military action across the globe, leading to improved patient outcomes.
Visit http://www.kci1.com for more information.
Line of Advanced Silicone Gel Products Targeted at Wounds
Scapa Medical (Windsor, Conn) introduces a premiere line of advanced silicone gel adhesive products for direct skin applications, such as neonatal care, wound care, medical device attachment, and hypertrophic scarring reduction.
Scapa medical silicone gel products are soft nonirritating adhesives that are safe to use on even the most sensitive skin and will remove easily without causing any skin trauma.
Scapa silicone gels are available in a variety of breathable thermal co-polymer films and nonwoven materials. The silicone gels wash off with water and regain their adhesion when properly dried.
Call 800-653-5312 or visit http://www.scapamedical.com for more information.
New Applicator Delivers Hemostatic Powder to Surgical Wounds
Medafor Inc (Minneapolis, Minn) introduces the FlexiTip™ applicator for use with its Arista™ AH Absorbable Hemostat. Arista AH is the simple, safe, and effective hemostatic powder recently approved by the US Food and Drug Administration (FDA) for types of surgeries including cardiac, orthopedic, spinal, and general surgical applications.
The FlexiTip applicator is a lightweight plastic device with a long, flexible tube to provide accurate delivery of Arista AH powder deep into hemorrhagic wounds and into difficult reach locations during surgery. The Arista AH bellows applicator attaches to the end of the FlexiTip to create a reservoir of powder that flows through the tube when the bellows are compressed.
Arista AH is the only new generation surgical hemostat that is instantly ready to use, requiring no mixing, and no addition of patient blood or other components. There are no special handling or storage conditions. Arista AH facilitates the formation of a highly resilient, natural clot within just a few minutes regardless of the patient’s coagulation status.
Visit http://www.medafor.com for more information.
Healtheuniverse Advances Stem Cell Applications for Wound Healing
Healtheuniverse Inc (Covina, Calif) announces that the company’s patented adult stem technology will be used to advance commercial applications focused on accelerated wound healing with decreased scarring.
The company is expanding its presence in the wound care field and is working on the development of living wound healing products and bioengineered surgical products based on its proprietary adult stem cell technology.
Wound care is currently estimated to be a $100 billion market in the US and growing significantly. Through internal and external research within the wound care area, Healtheuniverse can also strengthen their product lines in the plastic, reconstructive, and cosmetic surgery markets.
Healtheuniverse believes the company will be able to bring a dramatic improvement in care to patients in their clinics by offering the newest and latest advances in stem cell therapy.
Visit http://www.healtheuniverse.com for more information.
UK Launch of New Wound Care Technology Debuted at International Wound Conference
Greystone Pharmaceuticals Inc (Memphis, Tenn), through its European subsidiary Dermagenics Europe, announces the UK launch of its chronic wound technology, Epi-Max EU™.
Epi-Max EU is noted for use as a wound dressing to manage diabetic ulcers, decubitus ulcers, leg ulcers, and acute severe wounds where fast epithelialization is required. This is the first wound care product allowed to claim the ability to down regulate matrix metalloproteases (MMP) production. Studies have shown this down regulation enhances the healing of chronic and acute severe wounds.
The product is currently marketed and sold under the DerMax® name throughout Europe and the Middle East. Encouraged by the success of DerMax throughout the continent, Dermagenics looks forward to presenting the health care community with wound care alternatives that are effective in accelerating the healing process.
The product, which has been approved for the Drug Tariff list, is now available for distribution.
Visit http://www.greystonepharmaceuticals.com for more information. |
